Contributing factors to dry eye

Article

A comparison of self-reported dry-eye symptoms after LASIK procedures in men and women

Almost nine years ago Dr Edward E. Manche had not noticed any difference in dryeye symptoms after switching from the mechanical keratome to the femtosecond laser. However, as a result of anecdotal evidence that femtosecond laser flaps during LASIK might produce a lower incidence of dry eye, Dr Manche and Dr Lilya Golas performed a comparative study to determine the truth of the matter.1

Femtosecond vs mechanical

"The outcome of the study mirrored my clinical impression between the two procedures, that there was no difference in dry eye symptoms switching between techniques," revealed Dr Manche. "The one finding that did surprise me was the difference in reported symptoms of postoperative dry eye between men and women."

The setbacks of self-diagnosis

The study was based on patient self-reporting symptoms, where each patient completed a questionnaire 1, 3, 6 and 12 months postoperatively. According to Dr Manche this self-reporting could be one of the reasons why a difference between the male and female participants was observed. He explained, "If you look at the preoperative dry-eye score between men and women, you see that women graded their reported dry-eye score as almost double that of the men. This was not surprising, as women tend to have a higher incidence of dry eye. However, postoperatively, the men had a reported dry-eye score of almost double that of women at almost every time interval."

This lower preoperative dry-eye score from the male participants could attribute to the surprising outcome. Since the baseline level of dry-eye score was lower to begin with, even a small increase in self-reported dryness might then be graded at a higher number. "This shows that additional research is needed in this area," added Dr Manche.

Dr Manche iterated that the study could have been improved and more symptoms identified if dry-eye symtoms were not self-reported. "The study could be improved by adding physical findings at the slit-lamp examination including but not limited to vital dye staining, presence of any punctate epithelial erosions, and Schirmer testing," he said.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.